BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 16140764)

  • 21. Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.
    Drexler I; Staib C; Kastenmuller W; Stevanović S; Schmidt B; Lemonnier FA; Rammensee HG; Busch DH; Bernhard H; Erfle V; Sutter G
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):217-22. PubMed ID: 12518065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies.
    Wiser I; Balicer RD; Cohen D
    Vaccine; 2007 Jan; 25(6):976-84. PubMed ID: 17074424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleotide sequence of 21.8 kbp of variola major virus strain Harvey and comparison with vaccinia virus.
    Aguado B; Selmes IP; Smith GL
    J Gen Virol; 1992 Nov; 73 ( Pt 11)():2887-902. PubMed ID: 1331292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.
    Snyder JT; Belyakov IM; Dzutsev A; Lemonnier F; Berzofsky JA
    J Virol; 2004 Jul; 78(13):7052-60. PubMed ID: 15194781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic sequence and virulence of clonal isolates of vaccinia virus Tiantan, the Chinese smallpox vaccine strain.
    Zhang Q; Tian M; Feng Y; Zhao K; Xu J; Liu Y; Shao Y
    PLoS One; 2013; 8(4):e60557. PubMed ID: 23593246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microarray assay for evaluation of the genetic stability of modified vaccinia virus Ankara B5R gene.
    Laassri M; Meseda CA; Williams O; Merchlinsky M; Weir JP; Chumakov K
    J Med Virol; 2007 Jun; 79(6):791-802. PubMed ID: 17457926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3.
    Osborne JD; Da Silva M; Frace AM; Sammons SA; Olsen-Rasmussen M; Upton C; Buller RM; Chen N; Feng Z; Roper RL; Liu J; Pougatcheva S; Chen W; Wohlhueter RM; Esposito JJ
    Vaccine; 2007 Dec; 25(52):8807-32. PubMed ID: 18037545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the complete genome of smallpox variola major virus strain Bangladesh-1975.
    Massung RF; Liu LI; Qi J; Knight JC; Yuran TE; Kerlavage AR; Parsons JM; Venter JC; Esposito JJ
    Virology; 1994 Jun; 201(2):215-40. PubMed ID: 8184534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccinia virus-induced smallpox postvaccinal encephalitis in case of blood-brain barrier damage.
    Garcel A; Fauquette W; Dehouck MP; Crance JM; Favier AL
    Vaccine; 2012 Feb; 30(7):1397-405. PubMed ID: 22227123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioterrorism. Smallpox vaccinations: how much protection remains?
    Cohen J
    Science; 2001 Nov; 294(5544):985. PubMed ID: 11691969
    [No Abstract]   [Full Text] [Related]  

  • 32. Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus.
    Medaglia ML; Moussatché N; Nitsche A; Dabrowski PW; Li Y; Damon IK; Lucas CG; Arruda LB; Damaso CR
    J Virol; 2015 Dec; 89(23):11909-25. PubMed ID: 26378174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of vaccinia virus-neutralizing antibody in the sera of smallpox vaccinees.
    Viner KM; Isaacs SN
    Microbes Infect; 2005 Apr; 7(4):579-83. PubMed ID: 15848274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified vaccinia Ankara: potential as an alternative smallpox vaccine.
    McCurdy LH; Larkin BD; Martin JE; Graham BS
    Clin Infect Dis; 2004 Jun; 38(12):1749-53. PubMed ID: 15227622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.
    Meseda CA; Weir JP
    Future Microbiol; 2010 Sep; 5(9):1367-82. PubMed ID: 20860482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deletion of major nonessential genomic regions in the vaccinia virus Lister strain enhances attenuation without altering vaccine efficacy in mice.
    Dimier J; Ferrier-Rembert A; Pradeau-Aubreton K; Hebben M; Spehner D; Favier AL; Gratier D; Garin D; Crance JM; Drillien R
    J Virol; 2011 May; 85(10):5016-26. PubMed ID: 21367889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Profiling of the antibody response to attenuated LC16m8 smallpox vaccine using protein array analysis.
    Eto A; Fujita M; Nishiyama Y; Saito T; Molina DM; Morikawa S; Saijo M; Shinmura Y; Kanatani Y
    Vaccine; 2019 Oct; 37(44):6588-6593. PubMed ID: 31540810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alastrim smallpox variola minor virus genome DNA sequences.
    Shchelkunov SN; Totmenin AV; Loparev VN; Safronov PF; Gutorov VV; Chizhikov VE; Knight JC; Parsons JM; Massung RF; Esposito JJ
    Virology; 2000 Jan; 266(2):361-86. PubMed ID: 10639322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain.
    Lu B; Yu W; Huang X; Wang H; Liu L; Chen Z
    J Biomed Biotechnol; 2011; 2011():970424. PubMed ID: 21765641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety, immunogenicity and protective efficacy in mice of a new cell-cultured Lister smallpox vaccine candidate.
    Ferrier-Rembert A; Drillien R; Meignier B; Garin D; Crance JM
    Vaccine; 2007 Nov; 25(49):8290-7. PubMed ID: 17964011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.